Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Financial Flexibility Index
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Financial Flexibility Index of 0.49x as of December 2025. Free cash flow of $68.82 Million (operating CF $41.05 Million minus capex $27.77 Million) represents 0% of total liabilities ($140.71 Million). Check Zhengye Biotechnology Holding Limited Or liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. See how liquid is Zhengye Biotechnology Holding Limited Or's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year free cash flow to debt coverage for Zhengye Biotechnology Holding Limited Ordinary Shares. For the full company profile including market capitalisation, see ZYBT market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | $68.82 Million | $41.05 Million | $140.71 Million | ▲ +0.0% |
| 2024 | 0.49x | $68.82 Million | $41.05 Million | $140.71 Million | ▲ +31.4% |
| 2023 | 0.37x | $59.78 Million | $48.18 Million | $160.62 Million | ▲ +35.7% |
| 2022 | 0.27x | $44.66 Million | $17.34 Million | $162.81 Million | ▼ -40.4% |
| 2021 | 0.46x | $58.20 Million | $31.81 Million | $126.44 Million | — |